FY2021 Funding Opportunities for the NIH Director’s Early Independence Award

The NIH Common Fund announces FY2021 funding opportunities for the NIH Director’s Early Independence Award in the High-Risk, High-Reward Research program.  The program provides unique opportunities for exceptionally creative scientists to pursue highly innovative approaches to address major challenges in biomedical or behavioral research.  Applications are welcome that propose any research topic relevant to the broad mission of NIH and from any eligible institution.  NIH especially encourages applications from women and members of groups that are underrepresented in NIH-funded research.

The Early Independence Award has separate funding opportunities available for COVID-19-related research to be supported by Emergency funds through the CARES Act.  Applicants should apply to the appropriate funding opportunity based on their research topic. Applications submitted to the Emergency and non-Emergency funding opportunities will be reviewed together at the same time using the same process.

FY2021 NIH Director’s Early Independence Award (DP5 – Clinical Trial Optional): RFA RM-20-014

Supports outstanding junior scientists with the intellect, scientific creativity, drive, and maturity to bypass the traditional postdoctoral training period and launch an independent research career.  Applicants must have recently completed or will soon complete her/his doctoral degree or clinical training and have the support and guarantee of an independent research position from a host institution.

  • Complete doctoral degree or clinical training between June 1, 2019 and September 30, 2021
  • In non-independent position at time of application
  • Cannot have served in a postdoctoral position more than 12 months following a previous, non-terminal degree
  • Single-PI applications only
  • Requires significant institutional commitment
  • Limited to two applications per institution
  • No preliminary data required
  • Up to $250,000 direct costs per year for up to 5 years
  • See website for more information and FAQs
  • Application deadline: September 4, 2020

FY2021 NIH Director’s Early Independence Award (DP5 – Clinical Trial Optional): COVID-19 Proposals RFA RM-20-021

Supports outstanding junior scientists with the intellect, scientific creativity, drive, and maturity bypass the traditional postdoctoral training period and launch an independent research career.  Applicants must have recently completed or will soon complete her/his doctoral degree or clinical training and have the support and guarantee of an independent research position from a host institution.

  • Proposal must be relevant to COVID-19 prevention, preparation, or response
  • Complete doctoral degree or clinical training between June 1, 2019 and September 30, 2021
  • In non-independent position at time of application
  • Cannot have served in a postdoctoral position more than 12 months following a previous, non-terminal degree
  • Single-PI applications only
  • Requires significant institutional commitment
  • Limited to two applications per institution
  • No preliminary data required
  • Up to $250,000 direct costs per year for up to 5 years
  • See website for more information and FAQs
  • Application deadline: September 4, 2020

The High-Risk High-Reward Research Program and other Common Fund programs are managed by the Office of Strategic Coordination, Division of Program Coordination, Planning, and Strategic Initiatives in the NIH Office of the Director, in partnership with the component NIH Institutes, Centers, and Offices.  The NIH Common Fund encourages collaboration and supports a series of exceptionally high impact, trans-NIH programs.

The National Institutes of Health (NIH) –“The Nation’s Medical Research Agency” – includes 27 Institutes and Centers and is a component of the U. S. Department of Health and Human Services.  It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments and cures for both common and rare diseases.

For more information about NIH and its programs, visit the NIH website.

Original post by NIH on May 22, 2020